COMPARISON OF COMPOSITE INDICES FOR DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: A POST-HOC ANALYSIS FROM SELECT-PSA 1

被引：1
|
作者：
Smolen, J. S. [1 ]
Lubrano, E. [2 ]
Kishimoto, M. [3 ]
Balanescu, A. [4 ]
Strand, V. [5 ]
Gao, T. [6 ]
Vranich, N. [6 ]
Lippe, R. [7 ]
Tillett, W. [8 ]
机构：
[1] Med Univ Vienna, Med, Vienna, Austria
[2] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, Campobasso, Italy
[3] Kyorin Univ, Sch Med, Dept Nephrol & Rheumatol, Tokyo, Japan
[4] Carol Davila Univ Med & Pharm, Dept Internal Med & Rheumatol, St Maria Hosp, Bucharest, Romania
[5] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA
[6] AbbVie Inc, Immunol, N Chicago, IL USA
[7] AbbVie Deutschland GmbH & Co KG, Immunol, Wiesbaden, Germany
[8] Royal Natl Hosp Rheumat Dis, Rheumatol, Bath, Avon, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.1279
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1025
引用
收藏
页码：824 / 824
页数：1
相关论文
共 50 条
  • [1] Comparison of Composite Indices for Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib: A Post-Hoc Analysis from SELECT-PsA 1
    Smolen, Josef
    Lubrano, Ennio
    Kishimoto, Mitsumasa
    Balanescu, Andra R.
    Strand, Vibeke
    Gao, Tianming
    Vranich, Nancy
    Lippe, Ralph
    Tillett, William
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3790 - 3792
  • [2] Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trials
    Cantini, Fabrizio
    Marchesoni, Antonio
    Novelli, Lucia
    Gualberti, Giuliana
    Marando, Francesca
    McDearmon-Blondell, Erin L.
    Gao, Tianming
    McGonagle, Dennis
    Salvarani, Carlo
    [J]. RHEUMATOLOGY, 2024,
  • [3] Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials
    Mease, Philip
    Kavanaugh, Arthur
    Gladman, Dafna
    FitzGerald, Oliver
    Soriano, Enrique R.
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinya
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laure
    [J]. RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 1181 - 1191
  • [4] Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials
    Philip Mease
    Arthur Kavanaugh
    Dafna Gladman
    Oliver FitzGerald
    Enrique R. Soriano
    Peter Nash
    Dai Feng
    Apinya Lertratanakul
    Kevin Douglas
    Ralph Lippe
    Laure Gossec
    [J]. Rheumatology and Therapy, 2022, 9 : 1181 - 1191
  • [5] EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY INVOLVEMENT OF WEIGHT-BEARING JOINT REGIONS: A POST HOC SUBGROUP ANALYSIS OF THE PHASE 3, RANDOMIZED, SELECT-PSA 1 AND SELECT-PSA 2 TRIALS
    Mizelle, K.
    Tillett, W.
    Ali, M.
    Iyile, T.
    Gao, T.
    Setty, A.
    Walsh, J. A.
    Coates, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1767 - 1768
  • [6] Efficacy of Upadacitinib in Patients with Psoriatic Arthritis Stratified by Involvement of Weight-bearing Joint Regions: A Post Hoc Subgroup Analysis of the Phase 3, Randomized, SELECT-PsA 1 and SELECT-PsA 2 Trials
    Mizelle, Kristi
    Tillett, William R.
    Ali, Mira
    Iyile, Thomas
    Gao, Tianming
    Setty, Arathi
    Walsh, Jessica A.
    Coates, Laura
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2805 - 2806
  • [7] Upadacitinib Effects on Entheseal Domain in Psoriatic Arthritis Patients - a Pooled "post-hoc" Analysis from Two Phase III Studies (Select PsA 1 and 2)
    Cantini, Fabrizio
    Marchesoni, Antonio
    Marando, Francesca
    Gualberti, Giuliana
    Novelli, Lucia
    Curradi, Giacomo
    McDearmon--Blondell, Erin
    Gao, Tianming
    Salvarani, Carlo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2789 - 2791
  • [8] Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1
    Strand, Vibeke
    Mease, Philip J.
    Soriano, Enrique R.
    Kishimoto, Mitsumasa
    Salvarani, Carlo
    Saffore, Christopher D.
    Zueger, Patrick
    McDearmon-Blondell, Erin
    Kato, Koji
    Gladman, Dafna D.
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1789 - 1808
  • [9] Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1
    Vibeke Strand
    Philip J. Mease
    Enrique R. Soriano
    Mitsumasa Kishimoto
    Carlo Salvarani
    Christopher D. Saffore
    Patrick Zueger
    Erin McDearmon-Blondell
    Koji Kato
    Dafna D. Gladman
    [J]. Rheumatology and Therapy, 2021, 8 : 1789 - 1808
  • [10] EFFICACY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND A LOW OR HIGH SWOLLEN JOINT COUNT: A SUBGROUP ANALYSIS OF 2 PHASE 3 STUDIES (SELECT-PsA 1 AND SELECT-PsA 2)
    Gossec, L.
    Gladman, D. D.
    Mcdearmon-Blondell, E.
    Sewerin, P.
    Ritchlin, C. T.
    Feng, D.
    Lertratanakul, A.
    Ranza, R.
    Tam, L. S.
    Marchesoni, A.
    Coates, L. C.
    Nash, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1308 - 1309
12345